Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,241 | -18,730 | -10,860 | -41,843 | -28,030 |
| Depreciation Amortization | 201 | 135 | 68 | 389 | 340 |
| Accounts payable and accrued liabilities | -1,528 | 2,266 | -263 | 1,605 | 852 |
| Other Working Capital | -4,643 | -968 | 1,064 | 1,613 | -362 |
| Other Operating Activity | 4,965 | 830 | 1,955 | 5,209 | 4,322 |
| Operating Cash Flow | $-23,246 | $-16,467 | $-8,036 | $-33,027 | $-22,878 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -435 | -432 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-435 | $-432 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6,426 | -6,426 | -2,198 | -4,398 | -2,199 |
| Common Stock Issued | 5,060 | 5,047 | 1,477 | 28,898 | 8,747 |
| Other Financing Activity | 1,858 | 1,858 | 0 | 0 | 0 |
| Financing Cash Flow | $492 | $479 | $-721 | $24,500 | $6,548 |
| Beginning Cash Position | 30,711 | 30,711 | 30,711 | 39,673 | 39,673 |
| End Cash Position | 7,957 | 14,723 | 21,954 | 30,711 | 22,911 |
| Net Cash Flow | $-22,754 | $-15,988 | $-8,757 | $-8,962 | $-16,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,246 | -16,467 | -8,036 | -33,027 | -22,878 |
| Capital Expenditure | N/A | N/A | N/A | -435 | -432 |
| Free Cash Flow | -23,246 | -16,467 | -8,036 | -33,462 | -23,310 |